Brought to you by:
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in full US cohort
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients. This is according to Catalin Toma, MD, from the University of Pittsburgh Medical Center, Pittsburgh, who presented outcomes for the…
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep vein thrombosis (DVT) versus proximal DVT. The findings were recently published in JAMA Cardiology. The differences…
CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in interventional approaches
This advertorial is sponsored by ACHL. For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for chronic limb-threatening ischemia (CLTI) coalesce into one important truth: the necessity of entering the operating…
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT). The first…
Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data
The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has announced. RESCUE is a prospective multicenter, single-arm pivotal trial evaluating patient outcomes after treatment of acute…
‘Leveraging multiple teams and cardiovascular specialists’
This quarter’s Leadership Corner features Young Erben, MD, interviewing Charles B. Ross, MD, chief of vascular and endovascular services at Piedmont Heart Institute, Piedmont Hospital, Atlanta, since 2012. I am highlighting the innovative work of Dr. Ross, current medical leader…
Viz.ai reveals launch of new AI-powered modules for pulmonary embolism, aortic disease
Viz.ai—a company focused on artificial intelligence (AI)-driven intelligent care coordination—today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism (PE) and aortic disease at the 2021 VEITHsymposium (Nov. 16–20) in Orlando, Florida. The new modules allow for…
AI triage solution for PE and aortic dissection receives FDA clearance
Medical imaging artificial intelligence (AI) specialist, Avicenna.AI, recently announced that it has received certification in the U.S. and European Union (EU) for CINA CHEST, its new AI solution that leverages deep learning algorithms for emergency triage of deadly vascular conditions. In…
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study. One in 20 PE diagnoses is categorized as high risk, and these are associated with a…
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
AMELIA ISLAND, Fla.—As a podium talk at the annual meeting of the American Venous Forum (AVF), it represented a bit of an outlier. It was, the presenter admitted, the only non-scientific talk on the program. But the speaker was no…